Home
Glenmark Pharmaceuticals Limited
Press Release Mar 21 2026
Business
Mar 21 2026
5 min read

Press Release Mar 21 2026

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 21, 2026, titled "Glenmark Pharmaceuticals Launches GLIPIQ (Semaglutide) In India. Setting a new benchmark in affordability for GLP-1 therapy, with weekly treatment starting at Rs. 325".

View Attachment